Confidential information is neither sold nor shared.
Our Story
- This disruptive technology uses an algorithm which results in a cumulative take home baby rate of >60%.
- The protocol was refined over 25 years of clinical practice.
- It uniquely integrates and collates long established methodologies with evidence-based validation to identify the cause(s) of the couple’s infertility.
- While alpha testing in 2020, an Ob/Gyn in Iowa successfully treated a couple in California, all while under Covid-19 restrictions. Thus it was demonstrated that an infertile patient can be treated remotely!
- The Doctor and the Patient apps are integrated and perform seamlessly.
- We are set to begin clinical beta testing soon with under the oversight of University of Illinois College of Medicine with the approval their Institutional Review Board (IRB).